title: Diabetic retinopathy: An update on treatment.
abstract: Diabetic retinopathy is a progressive disease that results from vascular injury due to chronic hyperglycemia. It is the leading cause of blindness in working-age adults in the US and is usually asymptomatic until late stages. Treatment with laser photocoagulation is effective at preventing severe vision loss; thus, diabetic patients should be referred for regular screening by an ophthalmologist. New inhibitors of vascular endothelial growth factor may provide targeted nonsurgical treatment to improve vision in diabetic retinopathy.
authors.affiliation: University of Colorado School of Medicine, Denver, 80045, USA.
authors.forename: Ryan J
authors.initials: RJ
authors.lastname: Fante
authors.forename: Vikram D
authors.initials: VD
authors.lastname: Durairaj
authors.forename: Scott C N
authors.initials: SC
authors.lastname: Oliver
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D003930:Diabetic Retinopathy / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D007267:Injections; D017075:Laser Coagulation / Q000379:methods*; D014821:Vitrectomy / Q000379:methods*; D014822:Vitreous Body
chemical_list: D020533:Angiogenesis Inhibitors